Actelion Submits the Registration Dossier for Macitentan (Opsumit) to the …

Published November 22, 2012

Actelion submits the registration dossier for macitentan (Opsumit) to the …

Filed under: drug abuse treatment outcome study

The United States Food and Drug Administration had already received the registration dossier on October 22 nd 2012. Macitentan, a novel oral dual endothelin receptor antagonist, was studied in the pivotal, long-term, event-driven Phase III outcome …
Read more on Reuters

Controlled chaos: Davison family thankful after adopting eighth child

Filed under: drug abuse treatment outcome study

Pamela said Grace was born drug addicted and had a stroke. … They have a son who is an attorney, a daughter who is set to receive her master's degree in nursing at the age of 22, a daughter who served in the military and is studying to treat combat …
Read more on The Flint Journal – MLive.com